Discuss This Drug

belantamab

CHEBI:CHEBI_747833

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
active_ingredient_strength
100 mg/mL
dosage_form
INJECTION, SUSPENSION, LIPOSOMAL
marketing_start_date
20200805
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
generic_name
belantamab
product_ndc
69443-017
labeler_name
Baxter Oncology GmbH
spl_id
2e5915be-bd4c-4be9-a6dd-56a322321556
active_ingredient_name
BELANTAMAB MAFODOTIN
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class